Atlas Trials

Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms

Clinical trial NCT02430623 · COMPLETED

Trial details

NCT number
NCT02430623
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Urinary Bladder Neoplasms
Start date
2015-01-01
Primary completion
2020-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.